Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.  EClinicalMedicine.  53. 2022
2022 National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.  Clinical Infectious Diseases.  74:2010-2019. 2022
2021 Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.  Clinical Transplantation.  35. 2021
2021 A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action.  American Journal of Transplantation.  21:1754-1764. 2021
2021 Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes.  Transplantation Direct.  2021
2020 Human immunodeficiency virus from life taking to life giving: expanding the donor pool by using HIV-positive donors.  Current Opinion in Organ Transplantation.  25:626-630. 2020
2020 Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results.  American Journal of Transplantation.  20:617-619. 2020
2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience.  Annals of Surgery.  271:177-183. 2020
2019 Successful optimization of antiretroviral regimens in treatment-experienced people living with HIV undergoing liver transplantation.  Transplant Infectious Disease.  21. 2019
2019 The effect of renal transplantation on left ventricular function, electrocardiography, and mechanical synchrony by gated myocardial perfusion imaging.  Journal of Nuclear Cardiology.  26:1962-1970. 2019
2019 Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.  American Journal of Transplantation.  19:1597-1598. 2019
2018 Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.  American Journal of Transplantation.  18:2579-2586. 2018
2018 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.  Annals of Surgery.  267:1161-1168. 2018
2018 Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.  Transplant Infectious Disease.  20. 2018
2017 Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.  American Journal of Transplantation.  17:3114-3122. 2017
2017 Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications.  Journal of Applied Laboratory Medicine.  2:309-321. 2017
2017 Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.  American Journal of Transplantation.  17:2712-2719. 2017
2017 Cell-Free DNA and active rejection in kidney allografts.  Journal of the American Society of Nephrology.  28:2221-2232. 2017
2017 Obesity increases the risk of end-stage renal disease among living kidney donors.  Kidney International.  91:699-703. 2017
2017 Survival benefit of kidney transplantation in HIV-infected patients.  Annals of Surgery.  265:604-608. 2017
2017 Access to kidney transplantation among HIV-infected waitlist candidates.  Clinical Journal of the American Society of Nephrology.  12:467-475. 2017
2017 Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients.  American Journal of Transplantation.  17:173-179. 2017
2016 Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients.  American Journal of Transplantation.  16:2377-2383. 2016
2016 Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients.  Transplantation.  100:141-146. 2016
2015 A national study of outcomes among HIV-infected kidney transplant recipients.  Journal of the American Society of Nephrology.  26:2222-2229. 2015
2015 Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.  American Journal of Transplantation.  15:2096-2104. 2015
2014 Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.  Transplantation.  97:446-450. 2014
2014 The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease.  Journal of Nuclear Cardiology.  21:739-746. 2014
2012 Renal transplantation in HIV patients: A series of four cases.  Indian Journal of Nephrology.  22:139-142. 2012
2010 QT prolongation is an independent predictor of mortality in end-stage renal disease.  Clinical Cardiology (Hoboken): an indexed and peer-reviewed journal for advances in the treatment of cardiovascular disease.  33:361-366. 2010

Chapter

Year Title Altmetric
2013 Specific etiologies.  199-236. 2013

Research Overview

  • Outcomes in Kidney transplantation
    HIV and kidney transplantation
    HIV and kidney donation
    Biomarkers in kidney allograft rejection
    Development of biological agents to optimize care in kidney transplant recipients .

    • Principal Investigator On

    Investigator On

  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • APOL1 Long-term kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Applying Precision MEdicine to Optimize Desensitization with NoveL BIOlogics or Cellular TheRApies in Highly SensiTized Kidney Transplant PatiEnts (AMELIORATE)  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER ^
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine ^
  • Establishing Normative Cognitive Data for UAB Medical Professionals  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • Hope in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC.
  • Private Grant  awarded by MALLINCKRODT, INC.
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by CSL BEHRING, LLC
  • Private Grant  awarded by MALLINCKRODT, INC.
  • Private Grant  awarded by NATERA, INC.
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC.
  • Private Grant  awarded by HANSA BIOPHARMA
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton

    • Education And Training

  • Maulana Azad Medical College, Internship
  • UAB Hospital, Internship
  • UAB Hospital, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, University of Delhi 2004

    • Full Name

  • Shikha Mehta